Balyasny Asset Management’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-286,533
Closed -$926K 3353
2025
Q3
$926K Buy
+286,533
New +$1.07M ﹤0.01% 2147
2025
Q1
Sell
-79,496
Closed -$308K 3077
2024
Q4
$308K Buy
+79,496
New +$525K ﹤0.01% 2373
2019
Q1
Sell
-45,690
Closed -$2.71M 1528
2018
Q4
$2.71M Sell
45,690
-29,414
-39% -$2.9M 0.02% 635
2018
Q3
$10.5M Buy
75,104
+29,266
+64% +$3.55M 0.05% 476
2018
Q2
$5.63M Buy
45,838
+7,329
+19% +$623K 0.03% 632
2018
Q1
$3.44M Buy
+38,509
New +$3.26M 0.01% 821
2016
Q4
Sell
-40,002
Closed -$1.59M 1428
2016
Q3
$1.59M Sell
40,002
-21,423
-35% -$973K 0.01% 638
2016
Q2
$4.42M Buy
61,425
+57,258
+1,374% +$4.53M 0.03% 535
2016
Q1
$334K Buy
4,167
+400
+11% +$31.6K ﹤0.01% 986
2015
Q4
$284K Sell
3,767
-262
-7% -$42.1K ﹤0.01% 986
2015
Q3
$1.54M Buy
+4,029
New +$1.82M 0.01% 692

Other funds holding LRMR